Citadel Advisors
PAHC icon

Citadel Advisors’s Phibro Animal Health PAHC Stock Holding History

Citadel Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
3,800
-5,200
-58% -$248K ﹤0.01% 11322
2025
Q4 		$336K Buy
+9,000
New +$366K ﹤0.01% 9888
2024
Q3 		– Sell
-4,900
Closed -$82.2K – 14951
2024
Q2 		$82.2K Sell
4,900
-5,100
-51% -$82K ﹤0.01% 11176
2024
Q1 		$129K Buy
10,000
+8,000
+400% +$95.9K ﹤0.01% 10985
2023
Q4 		$23.2K Buy
+2,000
New +$22.6K ﹤0.01% 12498
2023
Q3 		– Sell
-6,000
Closed -$82.2K – 14875
2023
Q2 		$82.2K Sell
6,000
-2,400
-29% -$34.4K ﹤0.01% 11213
2023
Q1 		$129K Buy
8,400
+3,900
+87% +$59.6K ﹤0.01% 10880
2022
Q4 		$60.3K Buy
+4,500
New +$60.3K ﹤0.01% 11907
2018
Q4 		– Sell
-8,200
Closed -$352K – 9594
2018
Q3 		$352K Buy
+8,200
New +$387K ﹤0.01% 7319
2017
Q3 		– Sell
-7,600
Closed -$282K – 7886
2017
Q2 		$282K Buy
+7,600
New +$248K ﹤0.01% 5999
2015
Q4 		– Sell
-3,500
Closed -$111K – 9058
2015
Q3 		$111K Buy
+3,500
New +$128K ﹤0.01% 6857
2015
Q2 		– Sell
-3,400
Closed -$120K – 8971
2015
Q1 		$120K Buy
3,400
+3,000
+750% +$96.6K ﹤0.01% 6690
2014
Q4 		$13K Sell
400
-600
-60% -$16.6K ﹤0.01% 8041
2014
Q3 		$22K Buy
+1,000
New +$20K ﹤0.01% 7360

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Citadel Advisors's PAHC Position: Q1 2026 in Review

Citadel Advisors sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 47,446 shares — an estimated $2.26M sold.

Citadel Advisors first reported a position in PAHC in Q2 2014 and held it in 38 quarters. The position peaked at $4.96M in Q1 2019. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Citadel Advisors reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 47,446 Phibro Animal Health shares in Q1 2026, an estimated $2.26M.
  • Citadel Advisors first reported a position in Phibro Animal Health in Q2 2014 and held it in 38 quarters.
  • Citadel Advisors's Phibro Animal Health position peaked at $4.96M in Q1 2019.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.